Professor, Internal Medicine, Yale University School of Medicine
Nephrology
Dr. Rex L. Mahnensmith, MD
|
|
Give Review
Doctor Rex L. Mahnensmith, MD practices Nephrology. He graduated from Yale University School of Medicine. Yale University School of Medicine is one of the top medical schools in the US. Yale University School of Medicine is ranked 7 in research and 57 in primary care medicine He received 2 awards: "Top Doctors: New York Metro Area" and "CMS Meaningful Use Stage 1 Certification". Dr. Rex L. Mahnensmith has written publications. He has 32 publications published with PubMed. The lastest paper is: 'Images in clinical medicine. Malignant hypertension.' He accepts all Medicare patients.
Publications
- Novel Treatments of Autosomal Dominant Polycystic Kidney Disease.
- Urgent-Start Peritoneal Dialysis: What are the Problems and Their Solutions?
- A quality improvement model for optimizing care of the diabetic end-stage renal Disease patient.
- Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.
- Abdominal wall Infection in a HIV patient on peritoneal dialysis.
- Intradialytic administration of amphotericin B: clinical observations on efficacy and safety.
- The prevalence and treatment of depression among patients starting dialysis.
- Hemodynamics in patients With intradialytic hypotension treated With cool dialysate or midodrine.
- Control of tartrate utilization in Aspergillus flavus.
- Interrelationships among quinidine, amiloride, and lithium as inhibitors of the Renal Na+-H+ exchanger.
- The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes.
- Advances in nephrology: a selected review of progress in care of the patient with renal Failure.
- Hypercalcemia, hypernatremia, and reversible Renal insufficiency.
- Effect of Acute metabolic acidemia on renal electrolyte transport in man.
- Experience with outpatient computed tomographic-guided Renal biopsy.
- Midodrine is effective and safe therapy for intradialytic Hypotension over 8 months of follow-up.
- Reduction in arteriovenous graft impairment: results of a vascular access surveillance protocol.
- Intradialytic Hypotension: is midodrine beneficial in symptomatic hemodialysis patients?
- Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis.
- Bone marrow transplant nephropathy: a case report and review of the literature.
- Dysuria in an elderly man With cardiomyopathy.
- Trimethoprim-sulfamethoxazole: Hyperkalemia is an important complication regardless of dose.
- Angiotensin-converting enzyme inhibitor therapy in Chronic hemodialysis patients: any evidence of erythropoietin resistance?
- A middle-aged woman With back and flank pain.
- Pericarditis associated with renal Failure: evolution and management.
- Treatment of Severe Intradialytic Hypotension With the Addition of High Dialysate Calcium Concentration to Midodrine and/or Cool Dialysate.
- ACE inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients.
- Midodrine and cool dialysate are effective therapies for symptomatic intradialytic Hypotension.
- Extreme hyperphosphatemia and Acute renal failure after a phosphorus-containing bowel regimen.
- Images in clinical medicine. Malignant Hypertension.
- Diabetic nephropathy: a comprehensive approach.
Schools
Yale University School Of Medicine
Yale
Procedures Preformed
- Arteriovenostomy for Renal Dialysis
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Alkalosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Top Doctors: New York Metro Area
- CMS Meaningful Use Stage 1 Certification
Education
-
Yale University School of Medicine -
Yale-New Haven Hospital
Hospital
-
Yale-New Haven Hospital
Drug Facts
| NPI NUMBER | 1760466528 | |
| NPPES Provider LastName | MAHNENSMITH | |
| NPPES Provider FirstName | REX | |
| NPPES Provider ZIPCode | 065103218 | |
| NPPES Provider State | CT | |
| Specialty Description | Nephrology | |
| Total Claim Count | 3902.0 | |
| Distinct Opioid Count | 7.0 | |
| Opioid Claim Count | 212.0 | |
| Percent Opioid Claims | 5.43 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760466528 |
| Last Name Of The Provider | MAHNENSMITH |
| First Name Of The Provider | REX |
| View All |
Similar Doctors
|
|
Dr. Kwabena T. Awuah, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shirin Shirani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fredric O. Finkelstein, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert Alpern, MD |
|
|
Dr. Radu R. Raducu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kolawole O. Atandeyi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hasan Fattah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hugh B. Carey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randy L. Luciano, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey Turner, MD |